Synthesis and anticancer activity of 2-(alkyl-, alkaryl-, aryl-, hetaryl-) [1,2,4]triazolo [1,5-c]quinazolines

Citations of this article
Mendeley users who have this article in their library.


The combinatorial library of novel potential anticancer agents, namely, 2-(alkyl -, alkaryl-, aryl-, hetaryl-) [1,2,4]triazolo [1,5-c]quinazolines, was synthesized by the heterocyclization of the alkyl -, alkaryl-, aryl-, hetarylcarboxylic acid (3H-quinazoline-4-ylidene)hydrazides by oxidative heterocyclization of the 4-(arylidenehydrazino)quinazolines using bromine, and by the heterocyclization of N-(2-cyanophenyl)formimidic acid ethyl ester. The optimal method for synthesis of the s-triazolo [1,5-c]quinazolines appeared to be cyclocondensation of the corresponding carboxylic acid (3H-quinazoline-4-ylidene)hydrazides. The compounds' structures were established by 1H, 13C NMR, LC-and EI-MS analysis. The in vitro screening of anticancer activity determined the most active compound to be 3,4,5-trimethoxy-N'-[quinazolin-4(3H)-ylidene]benzohydrazide (3.20) in micromolar concentrations with the GI50 level (MG_MID, GI50 is 2.29). Thus, the cancer cell lines whose growth is greatly inhibited by compound 3.20 are: non-small cell lung cancer (NCI-H522, GI50=0.34), CNS (SF-295, GI50=0.95), ovarian (OVCAR-3, GI50=0.33), prostate (PC-3, GI50=0.56), and breast cancer (MCF7, GI50=0.52), leukemia (K-562, GI50=0.41; SR, GI50=0.29), and melanoma (MDA-MB-435, GI50=0.31; SK-MEL-5, GI50=0.74; UACC-62, GI50=0.32). SAR-analysis is also discussed. © Kovalenko et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria.




Kovalenko, S. I., Antypenko, L. M., Bilyi, A. K., Kholodnyak, S. V., Karpenko, O. V., Antypenko, O. M., … Kolomoyets, O. S. (2013). Synthesis and anticancer activity of 2-(alkyl-, alkaryl-, aryl-, hetaryl-) [1,2,4]triazolo [1,5-c]quinazolines. Scientia Pharmaceutica, 81(2), 359–391.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free